Video Experimental Relacionado
Updated: Sep 9, 2025
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.7K
iCardio: la plataforma de datos del mundo real para enfermedades cardiovasculares basada en la población brasileña
Miriam Allein Zago Marcolino1,2, Ana Paula Beck da Silva Etges1,2, Luciana Rodrigues de Lara1,2
1National Institute of Science and Technology for Health Technology Assessment (IATS)-CNPq/Brazil (project: 465518/2014-1), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Mayo Clinic proceedings. Digital health
|September 2, 2025
Resumen
La plataforma iCardio ofrece análisis de datos del mundo real para el cuidado cardiovascular en Brasil. Esta herramienta de acceso abierto mejora la eficiencia, la calidad y la equidad en los servicios cardiovasculares a través de información basada en datos.
Área de la Ciencia:
- Medicina cardiovascular
- Informática de la salud
- Política de salud pública
Sus antecedentes:
- Los avances tecnológicos son cruciales para mejorar la eficiencia de la asistencia sanitaria y reducir el desperdicio.
- La gestión de servicios de atención complejos requiere sistemas robustos de gestión de datos.
- El campo cardiovascular en Brasil enfrenta desafíos en la accesibilidad y el análisis de datos.
Objetivo del estudio:
- Para presentar la implementación de iCardio, una solución analítica de acceso abierto en línea para datos cardiovasculares del mundo real en Brasil.
- Proporcionar una plataforma fácil de usar para evaluar la eficiencia, la calidad y la equidad del servicio cardiovascular.
- Apoyar las políticas de salud basadas en datos y la investigación en el campo cardiovascular de Brasil.
Principales métodos:
- Desarrolló una plataforma analítica basada en la web (iCardio) utilizando datos del mundo real de la población.
- Se utilizaron datos de hospitalización y mortalidad del Ministerio de Salud brasileño (2019-2020).
- Datos integrados de 291,490 pacientes en 558 centros de salud, que cubren operaciones cardiovasculares y procedimientos de intervención.
Principales resultados:
- La plataforma iCardio proporciona acceso a 17 indicadores clave para la evaluación de la atención cardiovascular.
- Las características incluyen 4 vistas analíticas: perfil del paciente, análisis basado en la ubicación, tasas de procedimiento y exploración detallada.
- Los datos se pueden estratificar por las características del paciente, los procedimientos, los centros de atención médica y la geografía.
Conclusiones:
- iCardio es un valioso recurso de acceso abierto en línea para datos cardiovasculares del mundo real en Brasil.
- La plataforma puede servir como una herramienta transformadora para sostener políticas de salud basadas en datos.
- Facilita la investigación y la toma de decisiones informadas para mejorar la atención cardiovascular en todo el país.
Videos de Conceptos Relacionados
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:25Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45